| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 40 | 2025 | 964 | 4.990 |
Why?
|
| Pneumonia, Bacterial | 15 | 2025 | 89 | 4.280 |
Why?
|
| Pneumonia | 12 | 2025 | 291 | 4.250 |
Why?
|
| STAT3 Transcription Factor | 12 | 2021 | 72 | 3.270 |
Why?
|
| Liver | 10 | 2024 | 868 | 2.120 |
Why?
|
| Neutrophils | 11 | 2025 | 378 | 2.110 |
Why?
|
| Pneumonia, Pneumococcal | 14 | 2022 | 28 | 2.100 |
Why?
|
| Escherichia coli Infections | 9 | 2015 | 89 | 1.910 |
Why?
|
| Transcription Factor RelA | 7 | 2019 | 50 | 1.530 |
Why?
|
| Lung Injury | 2 | 2022 | 36 | 1.470 |
Why?
|
| Streptococcus pneumoniae | 13 | 2024 | 66 | 1.460 |
Why?
|
| Acute-Phase Reaction | 5 | 2021 | 18 | 1.450 |
Why?
|
| Epithelial Cells | 8 | 2021 | 401 | 1.210 |
Why?
|
| Oncostatin M | 2 | 2021 | 3 | 1.170 |
Why?
|
| Animals | 63 | 2025 | 20967 | 1.120 |
Why?
|
| Neutrophil Infiltration | 6 | 2019 | 61 | 1.100 |
Why?
|
| Leukemia Inhibitory Factor | 3 | 2022 | 4 | 1.090 |
Why?
|
| Macrophages, Alveolar | 11 | 2022 | 64 | 1.090 |
Why?
|
| Immunity, Innate | 16 | 2021 | 803 | 1.080 |
Why?
|
| Klebsiella Infections | 5 | 2012 | 22 | 1.080 |
Why?
|
| Klebsiella pneumoniae | 5 | 2012 | 30 | 1.080 |
Why?
|
| Mice | 48 | 2025 | 11004 | 1.050 |
Why?
|
| Signal Transduction | 8 | 2024 | 3070 | 0.880 |
Why?
|
| Mice, Inbred C57BL | 29 | 2025 | 3450 | 0.850 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2022 | 4 | 0.780 |
Why?
|
| Endotoxemia | 3 | 2021 | 11 | 0.700 |
Why?
|
| Coinfection | 1 | 2021 | 58 | 0.680 |
Why?
|
| Airway Remodeling | 3 | 2021 | 22 | 0.650 |
Why?
|
| Sepsis | 2 | 2024 | 290 | 0.630 |
Why?
|
| Interleukin-11 | 1 | 2019 | 8 | 0.620 |
Why?
|
| Pulmonary Edema | 1 | 2019 | 30 | 0.610 |
Why?
|
| Respiratory Mucosa | 5 | 2019 | 56 | 0.600 |
Why?
|
| Myeloid Cells | 4 | 2020 | 94 | 0.600 |
Why?
|
| Smoke | 1 | 2018 | 24 | 0.580 |
Why?
|
| Chemokine CXCL5 | 3 | 2025 | 7 | 0.570 |
Why?
|
| Pulmonary Alveoli | 4 | 2017 | 43 | 0.560 |
Why?
|
| Chemokines, CXC | 4 | 2007 | 29 | 0.560 |
Why?
|
| Bronchoalveolar Lavage Fluid | 11 | 2017 | 93 | 0.550 |
Why?
|
| Mice, Knockout | 11 | 2022 | 2140 | 0.520 |
Why?
|
| Escherichia coli | 7 | 2017 | 718 | 0.520 |
Why?
|
| Acute-Phase Proteins | 3 | 2015 | 34 | 0.510 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2025 | 645 | 0.510 |
Why?
|
| Immunologic Memory | 6 | 2025 | 290 | 0.490 |
Why?
|
| Interleukin-6 | 6 | 2009 | 325 | 0.470 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2005 | 153 | 0.450 |
Why?
|
| Disease Resistance | 1 | 2014 | 24 | 0.430 |
Why?
|
| Macrophages | 7 | 2022 | 1053 | 0.430 |
Why?
|
| NF-kappa B | 3 | 2017 | 471 | 0.420 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2019 | 617 | 0.400 |
Why?
|
| Hepatocytes | 2 | 2012 | 220 | 0.390 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2012 | 10 | 0.390 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2014 | 72 | 0.380 |
Why?
|
| Transcriptome | 3 | 2025 | 396 | 0.380 |
Why?
|
| Mice, Transgenic | 10 | 2021 | 1297 | 0.370 |
Why?
|
| Endothelial Cells | 3 | 2024 | 193 | 0.370 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 45 | 0.360 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 2238 | 0.340 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2012 | 351 | 0.340 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 1622 | 0.320 |
Why?
|
| Lipopolysaccharides | 6 | 2021 | 625 | 0.320 |
Why?
|
| Cell Line | 8 | 2017 | 2057 | 0.320 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 266 | 0.300 |
Why?
|
| Ethanol | 3 | 2007 | 325 | 0.280 |
Why?
|
| Chemokine CXCL2 | 7 | 2016 | 15 | 0.270 |
Why?
|
| Cytokines | 6 | 2015 | 945 | 0.270 |
Why?
|
| Interleukin-1 | 2 | 2009 | 156 | 0.260 |
Why?
|
| RNA, Messenger | 13 | 2017 | 1552 | 0.260 |
Why?
|
| Inflammation | 5 | 2022 | 1163 | 0.260 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2005 | 11 | 0.250 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 103 | 0.230 |
Why?
|
| Apoptosis | 2 | 2022 | 1095 | 0.230 |
Why?
|
| Humans | 20 | 2025 | 64283 | 0.220 |
Why?
|
| Membrane Proteins | 2 | 2024 | 909 | 0.220 |
Why?
|
| Hypersensitivity | 1 | 2025 | 65 | 0.220 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 15 | 0.210 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2005 | 41 | 0.210 |
Why?
|
| CD40 Ligand | 1 | 2024 | 159 | 0.210 |
Why?
|
| Th17 Cells | 2 | 2025 | 62 | 0.210 |
Why?
|
| Respiratory Tract Infections | 1 | 2024 | 90 | 0.200 |
Why?
|
| Chemokines | 5 | 2008 | 93 | 0.190 |
Why?
|
| Interleukin-27 | 1 | 2022 | 6 | 0.190 |
Why?
|
| Hookworm Infections | 1 | 2022 | 11 | 0.180 |
Why?
|
| Cell Movement | 1 | 2003 | 466 | 0.180 |
Why?
|
| Extracellular Traps | 1 | 2022 | 44 | 0.180 |
Why?
|
| DNA-Binding Proteins | 4 | 2012 | 1197 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2177 | 0.170 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2020 | 1 | 0.160 |
Why?
|
| Asthma | 1 | 2025 | 471 | 0.160 |
Why?
|
| Male | 15 | 2025 | 30322 | 0.160 |
Why?
|
| Dinucleoside Phosphates | 1 | 2020 | 32 | 0.160 |
Why?
|
| Interferon-gamma | 4 | 2025 | 576 | 0.160 |
Why?
|
| Trachea | 2 | 2011 | 85 | 0.160 |
Why?
|
| Antigen Presentation | 1 | 2021 | 241 | 0.150 |
Why?
|
| Proteomics | 1 | 2021 | 294 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 57 | 0.150 |
Why?
|
| Natural Killer T-Cells | 1 | 2019 | 29 | 0.150 |
Why?
|
| Interleukins | 3 | 2022 | 80 | 0.150 |
Why?
|
| Kupffer Cells | 1 | 2019 | 43 | 0.150 |
Why?
|
| Neutrophil Activation | 2 | 2016 | 23 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 891 | 0.150 |
Why?
|
| Cell Survival | 1 | 2021 | 582 | 0.150 |
Why?
|
| Interleukin-17 | 4 | 2025 | 101 | 0.150 |
Why?
|
| Hematopoiesis | 2 | 2017 | 125 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 572 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2011 | 625 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 165 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2020 | 1366 | 0.140 |
Why?
|
| Acute Disease | 1 | 2019 | 671 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 214 | 0.130 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2017 | 11 | 0.130 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2017 | 9 | 0.130 |
Why?
|
| Immunity, Heterologous | 1 | 2017 | 11 | 0.130 |
Why?
|
| Pluripotent Stem Cells | 1 | 2017 | 74 | 0.130 |
Why?
|
| Necrosis | 1 | 2017 | 146 | 0.130 |
Why?
|
| Pneumococcal Infections | 2 | 2024 | 38 | 0.130 |
Why?
|
| Alcoholic Intoxication | 2 | 2007 | 27 | 0.120 |
Why?
|
| Microbiota | 1 | 2018 | 136 | 0.120 |
Why?
|
| Argonaute Proteins | 1 | 2017 | 147 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2016 | 705 | 0.120 |
Why?
|
| Rats | 5 | 2011 | 2005 | 0.120 |
Why?
|
| Brain | 1 | 2024 | 1581 | 0.120 |
Why?
|
| Biomarkers | 1 | 2021 | 1431 | 0.120 |
Why?
|
| RNA-Binding Proteins | 2 | 2017 | 446 | 0.110 |
Why?
|
| Granulocytes | 2 | 2005 | 73 | 0.110 |
Why?
|
| Leukocyte Count | 2 | 2005 | 99 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2012 | 697 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 775 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 1496 | 0.100 |
Why?
|
| Smoking | 1 | 2018 | 861 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2014 | 153 | 0.100 |
Why?
|
| Uridine | 1 | 2012 | 22 | 0.100 |
Why?
|
| Female | 8 | 2025 | 33382 | 0.100 |
Why?
|
| Serum Amyloid P-Component | 1 | 2012 | 2 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 85 | 0.090 |
Why?
|
| Serum Amyloid A Protein | 1 | 2012 | 7 | 0.090 |
Why?
|
| Antigens, Differentiation | 2 | 2023 | 141 | 0.090 |
Why?
|
| Gene Expression | 1 | 2015 | 851 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2012 | 206 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 96 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 2 | 2009 | 205 | 0.090 |
Why?
|
| Chemokine CXCL1 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 132 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 297 | 0.090 |
Why?
|
| Catheterization | 1 | 2011 | 113 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 196 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 901 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 785 | 0.080 |
Why?
|
| Uridine Monophosphate | 1 | 2009 | 9 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 2 | 2007 | 36 | 0.080 |
Why?
|
| Chemokine CCL4 | 2 | 2005 | 14 | 0.070 |
Why?
|
| RAW 264.7 Cells | 2 | 2020 | 55 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 783 | 0.070 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2007 | 9 | 0.070 |
Why?
|
| Ozone | 1 | 2007 | 18 | 0.070 |
Why?
|
| Time Factors | 4 | 2017 | 3725 | 0.070 |
Why?
|
| Central Nervous System Depressants | 1 | 2007 | 46 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 869 | 0.060 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 50 | 0.060 |
Why?
|
| Leukocytes | 2 | 2021 | 103 | 0.060 |
Why?
|
| Monokines | 2 | 2004 | 4 | 0.060 |
Why?
|
| Opsonin Proteins | 1 | 2006 | 30 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 216 | 0.060 |
Why?
|
| Gram-Positive Bacteria | 1 | 2006 | 36 | 0.060 |
Why?
|
| Acrylic Resins | 1 | 2006 | 21 | 0.060 |
Why?
|
| Ligands | 2 | 2023 | 417 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2021 | 668 | 0.060 |
Why?
|
| Mucin 5AC | 1 | 2025 | 8 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2005 | 127 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2006 | 182 | 0.060 |
Why?
|
| Peroxidase | 1 | 2005 | 70 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 59 | 0.060 |
Why?
|
| Ovalbumin | 1 | 2025 | 116 | 0.060 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2004 | 12 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2006 | 151 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2005 | 181 | 0.050 |
Why?
|
| Chemokine CXCL13 | 1 | 2024 | 8 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2003 | 58 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 122 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2024 | 203 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2025 | 404 | 0.050 |
Why?
|
| Endotoxins | 1 | 2003 | 82 | 0.050 |
Why?
|
| Chemotactic Factors | 1 | 2002 | 26 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 1019 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 140 | 0.050 |
Why?
|
| Mice, Inbred C3H | 3 | 2009 | 176 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2013 | 302 | 0.050 |
Why?
|
| Virulence | 2 | 2017 | 195 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2002 | 57 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 71 | 0.040 |
Why?
|
| Base Sequence | 2 | 2017 | 1335 | 0.040 |
Why?
|
| Tuberculosis | 1 | 2005 | 303 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 235 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 136 | 0.040 |
Why?
|
| Spleen | 1 | 2002 | 483 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 209 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 430 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2005 | 416 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1002 | 0.040 |
Why?
|
| Leukocyte Disorders | 1 | 2019 | 2 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 357 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 671 | 0.040 |
Why?
|
| Immune System Diseases | 1 | 2019 | 19 | 0.040 |
Why?
|
| Kidney | 1 | 2002 | 455 | 0.040 |
Why?
|
| Cell Communication | 1 | 2019 | 132 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2007 | 948 | 0.040 |
Why?
|
| Models, Biological | 2 | 2017 | 1187 | 0.040 |
Why?
|
| Histones | 1 | 2022 | 486 | 0.040 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2017 | 4 | 0.030 |
Why?
|
| Pulmonary Surfactants | 1 | 2017 | 12 | 0.030 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 13 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 458 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2017 | 21 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2017 | 29 | 0.030 |
Why?
|
| Cell Separation | 1 | 2017 | 146 | 0.030 |
Why?
|
| Serogroup | 1 | 2017 | 35 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2017 | 100 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2017 | 260 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 82 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2016 | 53 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 237 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2017 | 183 | 0.030 |
Why?
|
| Butyrate Response Factor 1 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Interleukin-23 Subunit p19 | 2 | 2005 | 3 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2016 | 187 | 0.030 |
Why?
|
| Interleukin-23 | 2 | 2005 | 18 | 0.030 |
Why?
|
| Epithelium | 1 | 2014 | 96 | 0.030 |
Why?
|
| Child | 1 | 2023 | 4583 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 35 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 45 | 0.020 |
Why?
|
| United States | 1 | 2025 | 7923 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 608 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 37 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 191 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2012 | 137 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2011 | 49 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 176 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2011 | 110 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 41 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 313 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2011 | 150 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 542 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 674 | 0.020 |
Why?
|
| UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 1 | 2009 | 1 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 696 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 396 | 0.020 |
Why?
|
| RNA Stability | 1 | 2009 | 103 | 0.020 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2009 | 144 | 0.020 |
Why?
|
| RNA | 1 | 2011 | 429 | 0.020 |
Why?
|
| Chemokine CXCL11 | 1 | 2007 | 4 | 0.020 |
Why?
|
| Chemokine CXCL9 | 1 | 2007 | 23 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 54 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2007 | 25 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 14662 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2007 | 56 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2007 | 62 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 134 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 153 | 0.020 |
Why?
|
| Respiration | 1 | 2007 | 92 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 406 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2006 | 10 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 217 | 0.020 |
Why?
|
| Enterococcus faecalis | 1 | 2006 | 12 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1597 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1999 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 271 | 0.010 |
Why?
|
| Materials Testing | 1 | 2006 | 86 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2005 | 9 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 33 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 490 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 43 | 0.010 |
Why?
|
| Granuloma | 1 | 2005 | 43 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 46 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2005 | 64 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2005 | 65 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 179 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 178 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2006 | 266 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 295 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 402 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 1619 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 237 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 544 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 614 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 312 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 98 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 2633 | 0.010 |
Why?
|
| CD18 Antigens | 1 | 2002 | 30 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 2002 | 46 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 166 | 0.010 |
Why?
|
| Glucose | 1 | 2005 | 471 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 247 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2003 | 433 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2003 | 529 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 679 | 0.010 |
Why?
|